Zusammenfassung
Die Behandlung großer intraokularer Melanome stellt eine therapeutische Herausforderung
aufgrund der therapiebedingten Nebenwirkungen dar. Durch eine reine Bestrahlungstherapie
ist durch die resultierende Tumornekrose mit zunehmenden radiogenen Nebenwirkungen
zu rechnen. Bei anterior gelegenen Aderhaut-Ziliarkörpermelanomen bietet die transsklerale
Resektion in arteriellen Hypotonie und bei posterioren Tumoren die Endoresektion über
eine Pars-plana-Vitrektomie eine chirurgische Alternativbehandlung. Bei insgesamt
292 Patienten mit großen Ziliarkörper- bzw. Aderhautmelanomen wurde eine chirurgische
Resektion des Tumors durchgeführt. 150 Tumoren wurden transskleral reseziert und erhielten
anschließend eine adjuvante 106Ruthenium-Brachytherapie und 142 wurden mittels Protonen vorbestrahlt und wurden anschließend
durch eine Endoresektion exzidiert. Die mittlere Nachbeobachtungszeit war 3,8 bzw.
2,5 Jahre. Die lokale Tumorkontrolle betrug bei den transskleral resezierten Tumoren
76 % und bei den endoresezierten Tumoren 98 %. Die 5-Jahres-Metastasierungsrate war
28 % und 21 %. Der Augenerhalt war 82 % und 97 %. Die chirurgische Resektion von Ziliarkörper-
bzw. Aderhautmelanomen mit adjuvanter Bestrahlung ist bei großen Tumoren die Therapie
der Wahl, da bei der Mehrzahl der Patienten mit einem Augenerhalt zu rechnen ist,
ohne die tumorebezogenen Risiken zu erhöhen.
Abstract
The treatment of large uveal melanomas poses a therapeutic challenge, due to the expected
treatment-related side-effects. After sole radiotherapy the majority of patients are
faced with radiogenic complications secondary to the large amount of tumour necrosis.
Alternative treatment modalities addressing this issue are transscleral resection
in arterial hypotension in anteriorly located tumours and endoresection via pars plana
vitrectomy in posteriorly located tumours. A surgical resection treatment was applied
in 292 patients with large uveal melanomas. In 150 patients the tumour was treated
by transscleral resection and postoperative adjuvant 106ruthenium brachytherapy and 142 patients were treated by primary proton beam irradiation
and secondary endoresection. The mean follow-up time was 3.8 and 2.5 years, respectively.
Local tumour control was achieved in 76 % and 98 %, respectively. The 5-year metastatic
rates were 28 % and 21 % and eye retention was achieved in 82 % and 97 %, respectively.
Surgical resection of uveal melanomas with adjuvant radiotherapy is the treatment
of choice in cases of large tumours, avoiding enucleation in the vast majority of
cases in the long term, without increasing the incidence of tumour-related risks.
Schlüsselwörter
okuläre Tumoren - Retina - Chorioidea - Glaskörper
Key words
choroid - retina - vitreous - ocular tumours
Literatur
- 1
Lommatzsch P K, Staneczek W, Bernt H.
Epidemiologic study of new cases of intraocular tumors in East Germany 1961 – 1980.
Klin Monatsbl Augenheilkd.
1985;
187
487-492
- 2
Lommatzsch P K.
Radiotherapy of intraocular tumours, particularly of melanoma of the choroid (author’s
transl).
Klin Monatsbl Augenheilkd.
1979;
174
948-958
- 3
Gragoudas E S, Seddon J M, Egan K. et al .
Long-term results of proton beam irradiated uveal melanomas.
Ophthalmology.
1987;
94
349-353
- 4
Char D H, Gragoudas E S, Phillips T L.
Uveal melanoma management.
The British journal of ophthalmology.
1989;
73
476-477
- 5
Packer S.
Iodine-125 radiation of posterior uveal melanoma.
Ophthalmology.
1987;
94
1621-1626
- 6
Bechrakis N E, Foerster M H.
Where is the superiority of proton radiation for ocular tumours?.
Graefe’s archive for clinical and experimental ophthalmology.
2002;
240
513-514
- 7
Muller H K, Lund O E, Sollner F. et al .
The operative treatment of tumors of the chamber angle and ciliary body.
Documenta ophthalmologica.
1966;
20
500-518
- 8
Stallard H B.
Partial choroidectomy.
The British journal of ophthalmology.
1966;
50
660-662
- 9
Naumann G.
Block-excision of intraocular processes. I. Tumors of the anterior uvea (author’s
transl).
Klin Monatsbl Augenheilkd.
1975;
166
436-448
- 10
Naumann G, Hadlok I.
Technic of cyclectomy.
Ber Zusammenkunft Dtsch Ophthalmol Ges.
1974;
72
481-484
- 11
Naumann G O, Rummelt V.
Block excision of tumors of the anterior uvea. Report on 68 consecutive patients.
Ophthalmology.
1996;
103
2017-2027
- 12
Naumann G O, Volker H E, Gackle D.
The blockexcision of malignant melanomas of the ciliary body and the peripheral choroid.
Documenta ophthalmologica.
1980;
50
43-48
- 13
Foulds W S.
The local excision of choroidal melanomata.
Transactions of the ophthalmological societies of the United Kingdom.
1973;
93
343-346
- 14
Peyman G A, Charles H.
Internal eye wall resection in the management of uveal melanoma.
Canadian journal of ophthalmology.
1988;
23
218-223
- 15
Peyman G A, Cohen S B.
Ab interno resection of uveal melanoma.
Int Ophthalmol.
1986;
9
29-36
- 16
Peyman G A, Nelson N C, Paris C L. et al .
Internal choroidectomy of posterior uveal melanomas under a retinal flap.
Int Ophthalmol.
1992;
16
439-444
- 17
Damato Jr B, Groenewald C, McGalliard J. et al .
Endoresection of choroidal melanoma.
The British journal of ophthalmology.
1998;
82
213-218
- 18
Hocht S, Bechrakis N E, Nausner M. et al .
Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner
Institute.
Strahlenther Onkol.
2004;
180
419-424
- 19
Gragoudas E S, Li W, Lane A M. et al .
Risk factors for radiation maculopathy and papillopathy after intraocular irradiation.
Ophthalmology.
1999;
106
1571-1577
- 20
Char D H, Kroll S, Quivey J M. et al .
Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation
to enucleation versus brachytherapy.
The British journal of ophthalmology.
1996;
80
117-124
- 21
Bergman L, Nilsson B, Lundell G. et al .
Ruthenium brachytherapy for uveal melanoma, 1979 – 2003: survival and functional outcomes
in the Swedish population.
Ophthalmology.
2005;
112
834-840
- 22
Damato B.
Adjunctive plaque radiotherapy after local resection of uveal melanoma.
Frontiers of radiation therapy and oncology.
1997;
30
123-132
- 23
Damato B E, Paul J, Foulds W S.
Predictive factors of visual outcome after local resection of choroidal melanoma.
The British journal of ophthalmology.
1993;
77
616-623
- 24
Damato B E, Paul J, Foulds W S.
Risk factors for metastatic uveal melanoma after trans-scleral local resection.
The British journal of ophthalmology.
1996;
80
109-116
- 25
Collaborative Ocular Melanoma Study Group .
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year
mortality rates and prognostic factors: COMS report No. 28.
Archives of ophthalmology.
2006;
124
1684-1693
- 26
Karkhaneh R, Chams H, Amoli F A. et al .
Long-term surgical outcome of posterior choroidal melanoma treated by endoresection.
Retina.
2007;
27
908-914
- 27
Damato B, Wong D, Green F D. et al .
Intrascleral recurrence of uveal melanoma after transretinal ”endoresection”.
The British journal of ophthalmology.
2001;
85
114-115
- 28
Hadden P W, Hiscott P S, Damato B E.
Histopathology of eyes enucleated after endoresection of choroidal melanoma.
Ophthalmology.
2004;
111
154-160
- 29
Robertson D M.
Melanoma endoresection: a perspective.
Retina.
2001;
21
403-407
- 30
Mittica N, Vemuganti G K, Duffy M. et al .
Late orbital recurrence of a choroidal melanoma following internal resection: report
of a case and review of the literature.
Survey of ophthalmology.
2003;
48
181-190
- 31
Bechrakis N E, Foerster M H.
Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal
melanomas.
International ophthalmology clinics.
2006;
46
95-107
- 32
Bechrakis N E, Hocht S, Martus P. et al .
Endoresection following proton beam irradiation of large uveal melanomas.
Ophthalmologe.
2004;
101
370-376
- 33
Bornfeld N, Talies S, Anastassiou G. et al .
Endoscopic resection of malignant melanomas of the uvea after preoperative stereotactic
single dose convergence irradiation with the Leksell gamma knife.
Ophthalmologe.
2002;
99
338-344
- 34
Schilling H, Bornfeld N, Talies S. et al .
Endoresection of large uveal melanomas after pretreatment by single-dose stereotactic
convergence irradiation with the leksell gamma knife--first experience on 46 cases.
Klin Monatsbl Augenheilkd.
2006;
223
513-520
- 35
Bechrakis N E, Bornfeld N, Zoller I. et al .
Iodine-125 brachytherapy and trans-scleral tumor resection in large uveal melanomas.
Ophthalmologe.
2001;
98
736-742
- 36
Bechrakis N E, Bornfeld N, Zoller I. et al .
Iodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment
of large uveal melanomas.
Ophthalmology.
2002;
109
1855-1861
Prof. Nikolaos E. Bechrakis
Universitätsklinik für Augenheilkunde und Optometrie
Anichstr. 35
6020 Innsbruck
Österreich
Phone: ++ 43/5 12/50 42 37 20
Fax: ++ 43/5 12/50 42 37 22
Email: nikolaos.bechrakis@i-med.ac.at
